The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Low-Dose Naltrexone Could Treat Long COVID Symptoms
verywellhealth
07 June 2023
https://www.verywellhealth.com/low-dose-naltrexone-long-covid-treatment-7507283
A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia
Heliyon
19 April 2023
https://pubmed.ncbi.nlm.nih.gov/37206027/
Low-Dose Naltrexone in Rheumatological Diseases
Mediterr J Rheumatol
31 March 2023
https://pubmed.ncbi.nlm.nih.gov/37223594/
Background: Naltrexone has been approved for alcohol and opioid abuse by the FDA. At low-dose naltrexone (LDN) has been used in several diseases including chronic pain and autoimmune conditions, including rheumatic disorders.
Pilot Study of Low-Dose Naltrexone for the Treatment of Chronic Pain Due to Arthritis: A Randomized, Double-blind, Placebo-Controlled, Crossover Clinical Trial
Clin Ther
10 April 2023
https://pubmed.ncbi.nlm.nih.gov/37045708/
Low-dose naltrexone in the treatment of fibromyalgia: A systematic review and narrative synthesis
Aust J Gen Pract
April 2023
https://www1.racgp.org.au/ajgp/2023/april/low-dose-naltrexone-in-the-treatment-of-fibromyalg
Method: A systematic literature search was conducted using the key words 'naltrexone', 'fibromyalgia', 'fibrositis', 'chronic pain' and 'neurogenic inflammation'.
Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis
Biomedicines
As revised 23 March 2023
https://www.mdpi.com/2227-9059/11/4/1087
An Update on the Uses of Naltrexone in Clinical Practice
Natural Medicine Journal
01 August 2022
https://www.naturalmedicinejournal.com/journal/an-update-on-the-uses-of-naltrexone-in-clinical-practice
Deena - Canada: Update on her UCTD (Undifferentiated Connective Tissue Disease), Chronic HSV2/Shingles, Chronic Pain, IBS, Histamine Intolerance, Vestibular Migraine, and Insomnia (LDN; low dose naltrexone)